Schöllgroup:Publications

Home        Contact        Internal        Lab Members        Publications        Research        Talks       

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, Palmqvist S, Mattsson M, Janelidze S, Santillo A, Ohlsson T, Jögi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2018;320(11):1151-1162.

Palmqvist S*, Schöll M*, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O. *contributed equally. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nature Communications. 2017 Oct 31;8(1):1214. PubMed

Schöll M, Ossenkoppele R, Strandberg O, Palmqvist S; Swedish BioFINDER study, Jögi J, Ohlsson T, Smith R, Hansson O. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease Brain. 2017 Sep 1;140(9):2286-2294. PubMed

Schöll M,* Lockhart SN,* Schonhaut DR, O’Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici G, Jagust WJ. *contributed equally. PET imaging of tau deposition in the aging human brain. Neuron. 2016 Mar 2,89(5):971-82. PubMed F1000 evaluation (Very good)

Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Rasmuson S, Byström A, Långström B, Almkvist O, Graff C, Nordberg A. Low PIB PET but pathological CSF biomarkers in Arctic APP mutation carriers. Neurology. 2012 Jul 17,79(3):229-36. PubMed

Carter SF*, Schöll M*, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. *contributed equally. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-Deuterium-L-Deprenyl - A multi-tracer PET paradigm combining 11C-PIB and 18F-FDG. Journal of Nuclear Medicine. 2012 Jan,53(1):37-46. PubMed F1000 evaluation (Good)